Caribou Biosciences, Inc. Common Stock (NASDAQ: CRBU) last traded at $0.497, up 7.97% on the session. The quote above updates while this page is open; the figures below are drawn from Caribou Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Caribou Biosciences, Inc. Common Stock trades on NASDAQ under the ticker CRBU. Its market capitalisation is $53.27 million.
Valuation measures for Caribou Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $53.27M |
|---|---|
| Enterprise value | $71.75M |
| Price / sales | 5.31 |
| Price / book | 0.54 |
| Beta | 2.26 |
Trailing-twelve-month figures tagged in Caribou Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.04M |
|---|---|
| Net income (TTM) | -$103.40M |
| EPS (TTM) | -$1.08 |
| Operating margin | -1090.90% |
| Return on equity | -105.40% |
| Cash | $26.19M |
Range and volume for CRBU over the past 52 weeks.
| 52-week high | $3.54 |
|---|---|
| 52-week low | $0.443 |
| Volume | 5.25M |
| Average volume | 2.29M |
| Previous close | $0.460 |
Invest a chosen dollar amount in Caribou Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CRBU.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.